Profile data is unavailable for this security.
About the company
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.
- Revenue in USD (TTM)12.71bn
- Net income in USD435.50m
- Incorporated2024
- Employees67.00k
- LocationLabcorp Holdings Inc358 S Main StBURLINGTON 27215United StatesUSA
- Phone+1 (336) 229-1127
- Fax+1 (302) 636-5454
- Websitehttps://www.labcorp.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Encompass Health Corp | 5.22bn | 431.20m | 10.19bn | 22.36k | 23.93 | 5.20 | 11.92 | 1.95 | 4.23 | 4.11 | 51.10 | 19.45 | 0.8396 | -- | 9.38 | 233,270.70 | 9.07 | 6.37 | 11.87 | 7.94 | 95.49 | 95.58 | 10.80 | 9.16 | -- | 6.14 | 0.486 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
| Universal Health Services, Inc. | 15.42bn | 1.03bn | 13.07bn | 73.35k | 13.17 | 1.98 | 8.02 | 0.8478 | 15.03 | 15.03 | 225.85 | 100.14 | 1.09 | -- | 6.93 | 210,194.40 | 7.41 | 6.44 | 8.68 | 7.63 | -- | -- | 6.78 | 6.55 | 1.28 | 7.70 | 0.4105 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
| Davita Inc | 12.67bn | 827.68m | 13.57bn | 70.00k | 17.84 | 35.36 | 7.23 | 1.07 | 9.28 | 9.28 | 141.50 | 4.68 | 0.7357 | 71.34 | 5.90 | 180,951.60 | 6.58 | 5.62 | 8.88 | 7.45 | 32.80 | 30.70 | 8.94 | 8.33 | 1.33 | 4.77 | 0.8115 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
| Tenet Healthcare Corp | 20.97bn | 3.13bn | 13.66bn | 78.14k | 4.59 | 3.56 | 2.85 | 0.6513 | 31.26 | 31.26 | 209.81 | 40.32 | 0.7364 | 9.49 | 7.15 | 268,376.30 | 13.86 | 3.61 | 20.23 | 5.09 | 82.61 | 82.97 | 18.83 | 4.95 | 1.52 | 5.37 | 0.6145 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Molina Healthcare Inc | 39.20bn | 1.14bn | 16.63bn | 18.00k | 14.76 | 3.47 | 12.55 | 0.4243 | 19.70 | 19.70 | 674.97 | 83.68 | 2.56 | -- | 13.71 | 2,177,722.00 | 7.47 | 7.62 | 16.58 | 16.80 | 16.12 | 15.99 | 2.92 | 3.04 | -- | 14.83 | 0.3465 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
| Quest Diagnostics Inc | 9.54bn | 838.00m | 18.26bn | 40.00k | 21.96 | 2.69 | 13.68 | 1.91 | 7.45 | 7.45 | 84.79 | 60.79 | 0.645 | 34.77 | 7.18 | 238,475.00 | 5.87 | 9.28 | 6.77 | 10.81 | 32.94 | 36.64 | 9.10 | 12.97 | 1.17 | 8.87 | 0.4746 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Labcorp Holdings Inc | 12.71bn | 435.50m | 20.05bn | 67.00k | 46.45 | 2.46 | 18.98 | 1.58 | 5.16 | 5.16 | 150.40 | 97.61 | 0.7162 | 19.41 | 5.93 | 189,743.30 | 2.46 | 6.27 | 3.00 | 7.37 | 27.92 | 32.33 | 3.44 | 9.51 | 1.30 | 5.59 | 0.455 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Natera Inc | 1.53bn | -214.69m | 20.69bn | 3.28k | -- | 23.63 | -- | 13.50 | -1.77 | -1.77 | 12.59 | 7.08 | 1.01 | 14.29 | 5.45 | 466,774.80 | -14.14 | -36.17 | -17.55 | -46.60 | 57.66 | 45.88 | -14.01 | -56.15 | 4.23 | -- | 0.2947 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 9.26m | 11.08% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 4.55m | 5.45% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 3.73m | 4.46% |
| Diamond Hill Capital Management, Inc.as of 30 Sep 2024 | 1.98m | 2.37% |
| Geode Capital Management LLCas of 30 Sep 2024 | 1.96m | 2.35% |
| BlackRock Advisors LLCas of 30 Sep 2024 | 1.88m | 2.24% |
| Allspring Global Investments LLCas of 30 Sep 2024 | 1.82m | 2.17% |
| JPMorgan Investment Management, Inc.as of 30 Sep 2024 | 1.54m | 1.84% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 1.25m | 1.50% |
| Meridiem Investment Management Ltd.as of 30 Sep 2024 | 1.22m | 1.46% |
